A small study linked virtual group obesity care with continued weight loss. Read the results, limitations and questions to ask about ongoing support.
On September 17, 2026, Obesity Science & Practice published “Real-World Outcomes of Telemedicine Shared Medical Appointments in Obesity Management.” The paper described continued weight loss during a year of virtual group-based care among adults already participating in an obesity treatment program.
According to Medscape’s report on the study, the analysis included 109 adults who received telemedicine care from October 2023 to October 2024. Their mean age was 62.4 years and 81% were women. The program was insurance-based.
The timing within each person’s treatment matters. Participants had already spent an average of 17.8 months in the program and had lost an average of 6.9 kg before the study period began. This was a study of continued progress during established care, not a test of what happens when someone first starts treatment.
The study examined a way of delivering care rather than a new biological mechanism. Its practical focus was ongoing support for diet and lifestyle changes, with or without medication. The metabolic measurements were outcomes of that care rather than evidence of a newly identified pathway inside the body.
Medscape describes a model that combined an initial 40-minute individual appointment with a board-certified obesity medicine physician and weekly virtual shared medical appointments. Physicians provided individualized counseling and medication adjustments. A registered dietitian led group lifestyle classes.
Patients were asked to follow an individually tailored, portion-controlled balanced eating plan. That detail distinguishes the studied approach from a single diet prescription applied identically to everyone. The group format sat alongside individual medical attention rather than replacing it.
The practical idea was to keep nutrition guidance and medical management available within an ongoing program. Someone could receive group-based education while their physician addressed their individual treatment. That describes the care model’s intended operation, not a proven explanation for the results.
For readers considering virtual care, the important distinction is between the communication format and the care delivered through it. “Online” describes where these appointments happened. It does not capture the physician involvement or dietitian-led education that formed part of this particular program.
This also places the findings within a broader treatment conversation. WeightRestart’s coverage of medical care alongside lifestyle support offers related context for thinking about those elements together. Here, the research question concerned how ongoing care was organized after patients were already well into treatment.
Medscape’s headline used the phrase “may aid ongoing weight loss.” That cautious wording fits the evidence better than saying virtual group appointments produce a particular amount of weight loss. The news is an encouraging observation from one care program, not proof that this format is superior.
The authors offered a stronger interpretation. As quoted by Medscape, they described telemedicine shared medical appointments as an approach that “can be an efficient and effective approach to obesity management, in all stages.” That is their assessment of the findings rather than a conclusion established through comparison with another treatment model.
The central limitation is the study design. The analysis was retrospective and single-arm: it looked back at outcomes without a comparison group. It therefore cannot establish that the appointments caused the changes in weight or metabolic markers.
The program also bundled several components. Physician counseling and medication adjustments occurred alongside nutrition guidance and group classes. The results cannot separate the contribution of telemedicine from group support or the other parts of care.
The participants were a small, self-selected cohort composed mostly of women. Race and ethnicity information was missing. Those features limit how confidently the findings can be applied across different patient groups.
Follow-up ended at 12 months. The analysis therefore does not establish longer-term maintenance. Because participants were already engaged in treatment, its findings are also less directly applicable to people seeking initial care.
Finally, the average weight change is not a forecast for an individual patient. The A1c and triglyceride findings were secondary outcomes and do not establish prevention of diabetes or cardiovascular events. Keeping those boundaries clear allows the results to be useful without making them carry more meaning than the study supports.
Medscape reported changes relative to the beginning of the study period. That baseline came after participants had already spent time in the program. It was not their original starting point for treatment.
The reported averages were:
Both weight changes were statistically significant at P < .001. Both triglyceride reductions were statistically significant at P < .05, according to the report.
The six-month and 12-month weight figures are separate comparisons with the same study-period baseline. They should not be added together. The later figure describes the average change across the full observation period.
It is also important to preserve the units. The A1c change was reported in percentage points. That is different from describing it as a percentage reduction from the baseline value.
Taken together, the measurements show why this report is about more than a scale reading. The investigators tracked weight alongside metabolic markers. Readers interested in that broader perspective can also consider how to assess progress beyond body weight.
Although the program offered weekly virtual shared appointments, participants attended an average of 10.4 classes. Medscape reported that 64% attended at least five.
Weight loss did not differ significantly by sex, diabetes status, obesity-medication use, or number of classes attended. Those findings do not establish that the subgroups had equivalent outcomes. They also do not identify a minimum attendance requirement or show that more classes caused greater weight loss.
The useful distinction is between what a program offers and what this analysis established about participation. Weekly availability was a feature of the care model. A proven schedule for achieving a particular outcome was not a finding.
At WeightRestart, our focus is research-led and shame-free guidance for sustainable weight management. The practical value of this study is that it draws attention to continued care rather than treating the initial weight-loss phase as the whole task. Its structure gives readers concrete questions to bring to a discussion about support.
For someone considering a virtual program, questions grounded in the studied model include:
These are questions about the content of care, not instructions to reproduce this program independently. They also avoid judging a service solely by whether it uses video appointments or offers a group setting. Personal decisions about nutrition and medication belong with qualified care that can account for individual circumstances.
What to watch next is research that compares this model with other forms of ongoing obesity care. Studies should separate the contributions of group education and medical management while including more varied patient populations. Longer follow-up is needed to assess maintenance beyond the observation period reported here. Those answers would help establish whether this specific combination deserves a preferred role in routine care.
WeightRestart shares research-led guidance on weight loss, metabolism, nutrition, strength, appetite, sleep and recovery. Our goal is to make complex health information clear, practical and useful for people building progress they can maintain.
Learn how to build a weight-management approach around better information, realistic expectations and habits you can keep using.
read the blog
